newsfilter
← Latest News
GlobeNewswire·

Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results

●Q2 Revenue of $11.0 million; a 49% increase year-over-year; highest quarter in history ●Q2 Test volume up 15% year over year to record levels ●Q2 Reimbursement improvement up 34% year-over-year driven by additional